|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ste-reoselective metabolism of felodipine in liver micro-somes from rat, dog, and human显示文摘 | Eriksson UG Lundahl J Baarnhielm C | 1991 | Drug MetabDispos1991，19，5： | 1 |
| 2 | A turnover model of irreversible inhibition of gastric acid secretion by omeprazole in the dog显示文摘 | Abelo A Eriksson UG Karlsson MO | 2000 | J Pharmacol Exp Ther2000，295，2： | 1 |
| 3 | Effects of ximelagatran, an oral direct thrombin inhibitor,r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects 显示文摘 | Sarich TC Wolzt M Eriksson UG | 2003 | J Am Coll Cardiol2003，41，4： | 1 |
| 4 | Acute antithrombotic effects of ximelagalran,an oral direct thrombin inhibitor,and r-hirudin in a human ex vivo model of arterial thrombosis 显示文摘 | Sarich TC Osende JI Eriksson UG | 2003 | J Thromb Haemost2003，1，5： | 1 |
| 5 | Pharmacokinetics and pharmacodynamics of ximelagatran,a novel oral direct thrombin inhibitor,in young healthy male subjects显示文摘 | Eriksson UG Bredberg U Gislen K | 2003 | Eur J Clin Pharmacol2003，59，1： | 1 |
| 6 | Absorption distribution membolism and excretion of ximelagatran, an oral direct thrombin inhibitor, in rats, dogs, and humans 显示文摘 | Bredberg U Hoffmann KJ | 2003 | Drug Metal Dispos2003，31，29： | 1 |
| 7 | Absorption,distribution,metabolism,and excretion of ximelagatran,an oral direct thrombin inhibitor,in rats,dogs,and humans显示文摘 | Eriksson UG Bredberg U Hoffmann KJ | 2003 | Drug Metab Dispos2003，31，3： | 1 |
| 8 | Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement:results from Phase Ⅱ studies显示文摘 | Eriksson BI Ogren M Eriksson UG | 2002 | Thrombosis Res2002，105，： | 1 |
| 9 | Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatran 显示文摘 | Eriksson UG Johansson S Attman PO | 2003 | Clin Pharmacokinet2003，42，8： | 1 |
| 10 | Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatran显示文摘 | Eriksson UG Johansson S Attman PO | 2003 | Clin Pharmacokinet2003，42，8： | 1 |
| 11 | Pharmacokinetics and pharmacodynamics of ximelagatran,a novel oral direct thrombin inhibitor,in young healthy male subjects显示文摘 | Eriksson UG Bredberg U Gislen K | 2003 | Eur J Clin Pharmacol2003，59，1： | 1 |
| 12 | A pharmacokinetic study of the combined administration of amiodarone and ximelagatran,an oral dirrmacolect thrombin inhibitor显示文摘 | Teng R Sarich TC Eriksson UG | 2004 | J Clin Pharmacol2004，44，16： | 1 |
| 13 | A pharmacokinetic study of the combined administration of amiodarone and ximelagatran,an oral direct thrombin inhibitor 显示文摘 | Teng R Sarich TC Eriksson UG | 2004 | J Clin Pharmacol2004，44，9： | 1 |
| 14 | Absorption, distribution, metabolism and excretion of ximelagetran, an oral direct thorombin inhibitor in rats, dogs and humans 显示文摘 | Eriksson UG Bredberg U Hoffmann KJ | 2003 | Drug Metab Dispos2003，31，3： | 1 |
| 15 | Phar- macokinetics and pharmacodynamies of ximelagat-ran, a novel oral direct thrombin inhibitor, in young healthy male subjects显示文摘 | Eriksson UG Bredberg U Gislen K | 2003 | Eur J Clin Pharmacol2003，59，1： | 1 |
| 16 | Pharmakinetics and pharmacodynamics of ximelagetran, a novel oral direct thorombin inhibitor in young healthy male subjects 显示文摘 | Eriksson UG Bredberg U Gislen K | 2003 | Eur J Clin Pharnmcol2003，59，1： | 1 |
| 17 | Effects of ximelagatran, an oral direct thrombin inhibitor, rhirudin and enoxaparin on thrombin generation and platelet activation in heahhy male subjects显示文摘 | Sarich TC Wolzt M Eriksson UG | 2003 | J Am Coil Cardiol2003，41，55： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员